Suven Life Sciences - Quaterly Results

06 May 2024 Evaluate
The sales is pegged at Rs. 23.85 millions for the March 2024 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 26.11 millions during the year-ago period.The Net Loss for the quarter ended March 2024 is Rs. -31.25 millions as compared to Net Loss of Rs. -22.50 millions of corresponding quarter ended March 2023 Operating profit Margin for the quarter ended March 2024 further decreased to -25.87% as compared to -5.24% of corresponding quarter ended March 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 23.85 26.11 -8.66 116.93 135.39 -13.63 116.93 135.39 -13.63
Other Income 42.83 56.02 -23.55 211.30 84.49 150.09 211.30 84.49 150.09
PBIDT -25.87 -5.24 393.70 -98.07 -192.95 -49.17 -98.07 -192.95 -49.17
Interest 0.30 0.54 -44.44 1.58 2.89 -45.33 1.58 2.89 -45.33
PBDT -26.17 -5.78 352.77 -25.08 -135.84 -81.54 -25.08 -135.84 -81.54
Depreciation 15.10 16.72 -9.69 65.02 65.43 -0.63 65.02 65.43 -0.63
PBT -41.27 -22.50 83.42 -90.10 -201.27 -55.23 -90.10 -201.27 -55.23
TAX -10.02 0.00 0.00 -10.02 0.00 0.00 -10.02 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -31.25 -22.50 38.89 -80.08 -201.27 -60.21 -80.08 -201.27 -60.21
Equity 218.07 218.07 0.00 218.07 218.07 0.00 218.07 218.07 0.00
PBIDTM(%) -108.47 -20.07 440.49 -83.87 -142.51 -41.15 -83.87 -142.51 -41.15

Suven Life Sciences Share Price

92.65 -2.25 (-2.37%)
31-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1462.50
Dr. Reddys Lab 5784.50
Cipla 1451.25
Zydus Lifesciences 1001.15
Lupin 1587.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.